NCT05965297

Brief Summary

This study will investigate the clinical performance of a novel restorative glass ionomer (DeltaFil, DMG) in comparison to an established restorative glass ionomer (Riva Self Cure HV, SDI) in the restoration of Class II cavities in primary molars.

Trial Health

67
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
51mo left

Started Aug 2023

Longer than P75 for not_applicable

Geographic Reach
2 countries

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress40%
Aug 2023Aug 2030

First Submitted

Initial submission to the registry

July 20, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 28, 2023

Completed
4 days until next milestone

Study Start

First participant enrolled

August 1, 2023

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2027

Expected
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2030

Last Updated

July 28, 2023

Status Verified

July 1, 2023

Enrollment Period

4 years

First QC Date

July 20, 2023

Last Update Submit

July 20, 2023

Conditions

Keywords

Primary DentitionGlass ionomer cementsPosterior Class II restorationsDeltaFilRiva Self Cure HV

Outcome Measures

Primary Outcomes (1)

  • Survival rate of Class II restorations

    Restorations are clinically assessed using the Fédération Dentaire Internationale (FDI) criteria. A "surviving" restoration is defined as a restoration that is still present at the time of evaluation and has no individual FDI criteria with a score of 5 (clinically poor).

    24 months

Secondary Outcomes (2)

  • Survival rate of Class II restorations

    6, 12, 36, 48 and 60 months

  • Individual FDI parameter assessment

    Baseline, 6, 12, 24, 36, 48 and 60 months

Other Outcomes (2)

  • Caries Experience

    Baseline, 6, 12, 24, 36, 48 and 60 months

  • Oral Hygiene

    Baseline, 6, 12, 24, 36, 48 and 60 months

Study Arms (2)

DeltaFil

EXPERIMENTAL

Class II restorations are placed in primary molars after conventional cavity preparation.

Device: DeltaFil

Riva Self Cure HV

ACTIVE COMPARATOR

Class II restorations are placed in primary molars after conventional cavity preparation.

Device: Riva Self Cure HV

Interventions

DeltaFilDEVICE

Cavities are prepared using rotary instruments/diamond burs. Afterwards, the cavity is conditioned (using DeltaFil conditioner) and cleaned, with subsequent insertion of a conventional restorative glass-ionomer (DeltaFil). During the curing phase and after finishing Riva Coat will be applied to all restoration surfaces for moisture protection.

DeltaFil

Cavities are prepared using rotary instruments/diamond burs. Afterwards, the cavity is conditioned (using Riva conditioner) and cleaned, with subsequent insertion of a conventional restorative glass-ionomer (Riva Self Cure HV). During the curing phase and after finishing Riva Coat will be applied to all restoration surfaces for moisture protection.

Riva Self Cure HV

Eligibility Criteria

Age4 Years - 8 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • At least 1 and up to 3 primary molars with either International Caries Detection and Assessment System (ICDAS) lesions stage 2-5 or preexisting restorations requiring placement/replacement of Class II restorations
  • Defects limited to occlusal-proximal surface, with cavity sizes smaller than 3 mm mesio-distally and 3 mm in the occluso-cervical and bucco-lingual directions measured with a World Health Organization (WHO)-graded periodontal probe
  • Teeth should have both adjoining and their antagonist teeth present. After restoration the restored tooth should enable appropriate proximal contacts on both mesial and distal surfaces after setting of the class II restoration and be in occlusion with the antagonist tooth
  • Good access
  • Good general health (ASA I, II)
  • Good oral hygiene (OHI-S \< 1.9)
  • Guardians have given informed consent
  • Child is cooperative and assented

You may not qualify if:

  • Known allergy/ sensitivity to GIC or other materials used in this study
  • Space maintainers or orthodontic appliances
  • Tooth has a caries lesion or restoration other than those included in the study
  • Tooth has pathological mobility
  • Tooth has preexisting developmental defects
  • Tooth with pulp exposure or indication for endodontic treatment
  • Pain, fistula or abscess related to the selected tooth
  • Obvious signs of parafunctional habits (e.g. bruxism)
  • Participation in another study
  • Incapable to participate in the recall visits at the university hospital

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University Arthur Sá Earp Neto, Dental School - Pediatric Dentistry Clinic

Petrópolis, Brazil

Location

University of Coimbra, Faculty of Medicine, Paediatric and Preventive Dentistry Institute

Coimbra, Portugal

Location

Related Publications (1)

  • Hickel R, Peschke A, Tyas M, Mjor I, Bayne S, Peters M, Hiller KA, Randall R, Vanherle G, Heintze SD. FDI World Dental Federation: clinical criteria for the evaluation of direct and indirect restorations-update and clinical examples. Clin Oral Investig. 2010 Aug;14(4):349-66. doi: 10.1007/s00784-010-0432-8. Epub 2010 Jul 14.

    PMID: 20628774BACKGROUND

MeSH Terms

Conditions

Dental Caries

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic Diseases

Study Officials

  • Susanne Effenberger, Dr.

    DMG Dental Material Gesellschaft mbH

    STUDY CHAIR

Central Study Contacts

Marcus Cebula, Dr.

CONTACT

Susanne Effenberger, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Noninferiority trial
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2023

First Posted

July 28, 2023

Study Start

August 1, 2023

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

August 1, 2030

Last Updated

July 28, 2023

Record last verified: 2023-07

Locations